Form EFFECT Entasis Therapeutics
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | July 12, 2022 |
Accession Number: | 0001140361-22-025736 | ||||||
Submission Type: | POS AM | ||||||
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aviat Networks Sets Date for Its Fiscal 2024 Third Quarter Financial Results Announcement and Conference Call
- Augment Inc. Raises $227 Million at $977 Million Valuation to Empower Software Teams With AI
- Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value and Year-To-Date Return As Of 23 April 2024
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!